G Wieringa

727 total citations
16 papers, 496 citations indexed

About

G Wieringa is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, G Wieringa has authored 16 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Molecular Biology. Recurrent topics in G Wieringa's work include Growth Hormone and Insulin-like Growth Factors (9 papers), Pituitary Gland Disorders and Treatments (5 papers) and Lipid metabolism and disorders (4 papers). G Wieringa is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (9 papers), Pituitary Gland Disorders and Treatments (5 papers) and Lipid metabolism and disorders (4 papers). G Wieringa collaborates with scholars based in United Kingdom, Italy and Czechia. G Wieringa's co-authors include Peter Trainer, Ken Darzy, Ana Pokrajac, Gwen Wark, Ezio Ghigo, Gianluca Aimaretti, H. Rao Gattamaneni, S M Shalet, Stephen M. Shalet and G. M. Besser and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Endocrinology and European Journal of Endocrinology.

In The Last Decade

G Wieringa

15 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G Wieringa United Kingdom	11	419	116	79	66	59	16	496
S. Porretti Italy	10	425 1.0×	81 0.7×	79 1.0×	58 0.9×	46 0.8×	15	458
Ulla Feldt-Rasmussen Denmark	8	311 0.7×	70 0.6×	57 0.7×	118 1.8×	43 0.7×	10	470
M. C. Angelico United States	8	240 0.6×	202 1.7×	72 0.9×	149 2.3×	94 1.6×	13	558
Svetlana Zorić Serbia	11	229 0.5×	76 0.7×	62 0.8×	41 0.6×	35 0.6×	24	432
Harit Buch United Kingdom	11	245 0.6×	97 0.8×	49 0.6×	32 0.5×	31 0.5×	34	347
Ji Young Joung South Korea	15	315 0.8×	126 1.1×	41 0.5×	50 0.8×	15 0.3×	23	428
S. Munkgaard Rasmussen Denmark	8	154 0.4×	136 1.2×	46 0.6×	85 1.3×	39 0.7×	13	375
Cornelia Zwimpfer Switzerland	13	257 0.6×	51 0.4×	83 1.1×	101 1.5×	15 0.3×	22	397
John A. Scarlett United States	12	381 0.9×	179 1.5×	145 1.8×	71 1.1×	23 0.4×	14	590
Harvey K. Chiu United States	14	396 0.9×	243 2.1×	60 0.8×	313 4.7×	30 0.5×	28	562

Countries citing papers authored by G Wieringa

Since Specialization

Citations

This map shows the geographic impact of G Wieringa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Wieringa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Wieringa more than expected).

Fields of papers citing papers by G Wieringa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Wieringa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Wieringa. The network helps show where G Wieringa may publish in the future.

Co-authorship network of co-authors of G Wieringa

This figure shows the co-authorship network connecting the top 25 collaborators of G Wieringa. A scholar is included among the top collaborators of G Wieringa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Wieringa. G Wieringa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wieringa, G, et al.. (2020). The Academy of the European Federation of Clinical Chemistry and Laboratory Medicine and the European Register of Specialists in Laboratory Medicine: guide to the Academy and the Register, version 4 – 2020. Clinical Chemistry and Laboratory Medicine (CCLM). 59(3). 499–503. 1 indexed citations

Wieringa, G. (2018). Teaching the pony new tricks: competences for specialists in laboratory medicine to meet the challenges of disruptive innovation. Clinical Chemistry and Laboratory Medicine (CCLM). 57(3). 398–402. 12 indexed citations

Barraclough, Lisa, et al.. (2008). Estimation of Renal Function — What is Appropriate in Cancer Patients?. Clinical Oncology. 20(10). 721–726. 24 indexed citations

Paisley, Angela, et al.. (2007). Pegvisomant interference in GH assays results in underestimation of GH levels. European Journal of Endocrinology. 156(3). 315–319. 34 indexed citations

Pokrajac, Ana, et al.. (2007). Variation in GH and IGF‐I assays limits the applicability of international consensus criteria to local practice. Clinical Endocrinology. 67(1). 65–70. 130 indexed citations

Wieringa, G, Julian H. Barth, & Peter Trainer. (2004). Growth hormone assay standardization: a biased view?. Clinical Endocrinology. 60(5). 538–539. 16 indexed citations

Darzy, Ken, Gianluca Aimaretti, G Wieringa, et al.. (2003). The Usefulness of the Combined Growth Hormone (GH)-Releasing Hormone and Arginine Stimulation Test in the Diagnosis of Radiation-Induced GH Deficiency Is Dependent on the Post-Irradiation Time Interval. The Journal of Clinical Endocrinology & Metabolism. 88(1). 95–102. 123 indexed citations

Parkinson, Craig, WM Drake, G Wieringa, et al.. (2002). Serum lipoprotein changes following IGF‐I normalization using a growth hormone receptor antagonist in acromegaly. Clinical Endocrinology. 56(3). 303–311. 53 indexed citations

Murray, Robert, et al.. (2002). Low‐dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome. Clinical Endocrinology. 56(4). 525–532. 44 indexed citations

10.

Wieringa, G & Stephen M. Shalet. (2000). Changes in lipoprotein (a) levels measured by six kit methods during growth hormone treatment of growth hormone deficient adults. Growth Hormone & IGF Research. 10(4). 231–231. 3 indexed citations

11.

Wieringa, G. (2000). Lipoprotein(a): what's in a measure?. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 37(5). 571–580. 10 indexed citations

12.

Wieringa, G, Andy Toogood, W. David J. Ryder, et al.. (2000). Changes in lipoprotein(a) levels measured by six kit methods during growth hormone treatment of growth hormone-deficient adults. Growth Hormone & IGF Research. 10(1). 14–19. 17 indexed citations

13.

Wallymahmed, M, et al.. (1999). Apo E phenotype and changes in serum lipids in adult patients during growth hormone replacement. European Journal of Endocrinology. 140(2). 174–179. 16 indexed citations

14.

Wieringa, G, et al.. (1997). A Comparison of Three Procedures for the Detection of Bence–Jones Proteinuria. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 34(4). 371–374. 7 indexed citations

15.

Jones, Rhonda, et al.. (1993). Hypercholesterolaemia: not all cases warrant treatment.. BMJ. 307(6912). 1125–1126. 5 indexed citations

16.

Taylor, S. H., et al.. (1983). Sulphinpyrazone and renal function following myocardial infarction. European Journal of Clinical Pharmacology. 24(6). 747–750. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact